Literature DB >> 8641114

Gastric emptying in diabetes.

M F Kong1, I A Macdonald, R B Tattersall.   

Abstract

Gastric emptying abnormalities are common in diabetic patients but correlate poorly with gastrointestinal symptoms. Poor diabetic control is more likely to lead to gastrointestinal complications of diabetes and the converse is also true. Gastric emptying may be a previously under-recognized contributor to variations in glycaemic control in diabetes. There is evidence for both accelerated and delayed gastric emptying. More rapid gastric emptying would result in higher postprandial glucose levels and, therefore, pharmacological means to delay the rate of gastric emptying may be a new approach to slowing postprandial nutrient absorption and improving diabetic control. Hyperglycaemia reduces the rate of gastric emptying in both Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients. The exact mechanisms responsible for the inhibitory action of hyperglycaemia on gastric emptying are unknown. There is insufficient data on the effect of hypoglycaemia on gastric emptying but one study has reported more rapid gastric emptying.

Entities:  

Mesh:

Year:  1996        PMID: 8641114     DOI: 10.1002/(SICI)1096-9136(199602)13:2<112::AID-DIA37>3.0.CO;2-H

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance.

Authors:  Georgios C Boronikolos; Björn A Menge; Nina Schenker; Thomas G K Breuer; Jan-Michel Otte; Sascha Heckermann; Freimut Schliess; Juris J Meier
Journal:  Diabetologia       Date:  2015-03-01       Impact factor: 10.122

2.  Decreased gastric mechanodetection, but preserved gastric emptying, in CCK-1 receptor-deficient OLETF rats.

Authors:  Bart C De Jonghe; Andras Hajnal; Mihai Covasa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05-25       Impact factor: 4.052

3.  Changes of gastric emptying rate and gastrin levels are early indicators of autonomic neuropathy in type II diabetic patients.

Authors:  L Migdalis; T Thomaides; C Chairopoulos; C Kalogeropoulou; J Charalabides; F Mantzara
Journal:  Clin Auton Res       Date:  2001-08       Impact factor: 4.435

4.  Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations.

Authors:  R G Thompson; L Pearson; O G Kolterman
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

5.  Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model.

Authors:  Scott V Monte; Jerome J Schentag; Martin H Adelman; Joseph A Paladino
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

6.  Unanticipated full stomach at anesthesia induction in a type I diabetic patient with asymptomatic gastroparesis.

Authors:  Joho Tokumine; Kazuhiro Sugahara; Tatsuya Fuchigami; Koji Teruya; Kenichi Nitta; Kimiyoshi Satou
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

Review 7.  Carbohydrate and diabetes: is the source or the amount of more importance?

Authors:  M J Franz
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

Review 8.  Diagnosis and treatment of diabetic autonomic neuropathy.

Authors:  D Ziegler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 9.  Pramlintide for the treatment of insulin-requiring diabetes mellitus: rationale and review of clinical data.

Authors:  Davida F Kruger; Maurice A Gloster
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.

Authors:  C C Watkins; A Sawa; S Jaffrey; S Blackshaw; R K Barrow; S H Snyder; C D Ferris
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.